Search research articles
Contact Us
Filters
Showing results (11-20 of 123) with videos related to
Page
of 13
Sort By:
Cancer Research and Treatment
|
September 3, 2016
The Association between End-of-Life Care and the Time Interval between Provision of a Do-Not-Resuscitate Consent and Death in Cancer Patients in Korea
Sun Kyung Baek, Hye Jung Chang, Ja Min Byun, et al.
In Vivo (Athens, Greece)
|
February 27, 2019
Combination of Genetic Aberration With International Staging System Classification for Stratification of Asian Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Ja Min Byun, Daeyoon Kim, Dong-Yeop Shin, et al.
Clinical Laboratory
|
June 25, 2019
Hemoglobin Concentration Reference Interval Revisited: a Nationwide Study from Korea
John J Yang, Young Jin Kim, Taemi Youk, et al.
Annals of Hematology
|
December 29, 2016
Real world epidemiology of myeloproliferative neoplasms: a population based study in Korea 2004-2013
Ja Min Byun, Young Jin Kim, Taemi Youk, et al.
Scientific Reports
|
November 16, 2019
Distinctive patterns of peripheral neuropathy across the spectrum of plasma cell disorders
Ja Min Byun, Young Nam Kwon, Youngil Koh, et al.
Therapeutic Advances in Hematology
|
May 17, 2021
Busulfan plus melphalan <i>versus</i> melphalan alone conditioning regimen after bortezomib based triplet induction chemotherapy for patients with newly diagnosed multiple myeloma
Songyi Park, Dong-Yeop Shin, Junshik Hong, et al.
Anticancer Research
|
May 6, 2020
Characterization and Prognosis of Secondary Acute Myeloid Leukemia in an Asian Population: AML With Antecedent Hematological Disease Confers Worst Outcomes, Irrespective of Cytogenetic Risk
Sheehyun Kim, Sung-Soo Yoon, Junshik Hong, et al.
Cytotherapy
|
April 2, 2026
Role of salvage allogeneic transplantation for relapsed or refractory AML in nonremission: insights from real-world practice
Seungah Cha, Dong-Yeop Shin, Junshik Hong, et al.
Therapeutic Advances in Hematology
|
January 6, 2022
Association between preconditioning absolute lymphocyte count and transplant outcomes in patients undergoing matched unrelated donor allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and anti-thymocyte globulin
Jeongmin Seo, Dong-Yeop Shin, Youngil Koh, et al.
Journal of Clinical Medicine
|
July 29, 2020
Allogeneic Stem Cell Transplantation in Relapsed/Refractory Multiple Myeloma Treatment: Is It Still Relevant? (Running Title: The Role of Salvage alloSCT in MM)
Hyunkyung Park, Ja Min Byun, Sung-Soo Yoon, et al.
Page
of 13
Search research articles
Search
Showing results (11-20 of 123) with videos related to
Sort By:
Page
of 13
Cancer Research and Treatment
|
September 3, 2016
The Association between End-of-Life Care and the Time Interval between Provision of a Do-Not-Resuscitate Consent and Death in Cancer Patients in Korea
Sun Kyung Baek, Hye Jung Chang, Ja Min Byun, et al.
In Vivo (Athens, Greece)
|
February 27, 2019
Combination of Genetic Aberration With International Staging System Classification for Stratification of Asian Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Ja Min Byun, Daeyoon Kim, Dong-Yeop Shin, et al.
Clinical Laboratory
|
June 25, 2019
Hemoglobin Concentration Reference Interval Revisited: a Nationwide Study from Korea
John J Yang, Young Jin Kim, Taemi Youk, et al.
Annals of Hematology
|
December 29, 2016
Real world epidemiology of myeloproliferative neoplasms: a population based study in Korea 2004-2013
Ja Min Byun, Young Jin Kim, Taemi Youk, et al.
Scientific Reports
|
November 16, 2019
Distinctive patterns of peripheral neuropathy across the spectrum of plasma cell disorders
Ja Min Byun, Young Nam Kwon, Youngil Koh, et al.
Therapeutic Advances in Hematology
|
May 17, 2021
Busulfan plus melphalan <i>versus</i> melphalan alone conditioning regimen after bortezomib based triplet induction chemotherapy for patients with newly diagnosed multiple myeloma
Songyi Park, Dong-Yeop Shin, Junshik Hong, et al.
Anticancer Research
|
May 6, 2020
Characterization and Prognosis of Secondary Acute Myeloid Leukemia in an Asian Population: AML With Antecedent Hematological Disease Confers Worst Outcomes, Irrespective of Cytogenetic Risk
Sheehyun Kim, Sung-Soo Yoon, Junshik Hong, et al.
Cytotherapy
|
April 2, 2026
Role of salvage allogeneic transplantation for relapsed or refractory AML in nonremission: insights from real-world practice
Seungah Cha, Dong-Yeop Shin, Junshik Hong, et al.
Therapeutic Advances in Hematology
|
January 6, 2022
Association between preconditioning absolute lymphocyte count and transplant outcomes in patients undergoing matched unrelated donor allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and anti-thymocyte globulin
Jeongmin Seo, Dong-Yeop Shin, Youngil Koh, et al.
Journal of Clinical Medicine
|
July 29, 2020
Allogeneic Stem Cell Transplantation in Relapsed/Refractory Multiple Myeloma Treatment: Is It Still Relevant? (Running Title: The Role of Salvage alloSCT in MM)
Hyunkyung Park, Ja Min Byun, Sung-Soo Yoon, et al.
Page
of 13